Marianne P. Allen

Array ( [id] => 2722474 [patent_doc_number] => 05057416 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1991-10-15 [patent_title] => 'Supersecreting mutants of Saccharomyces cerevisiae' [patent_app_type] => 1 [patent_app_number] => 7/273362 [patent_app_country] => US [patent_app_date] => 1988-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7766 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/057/05057416.pdf [firstpage_image] =>[orig_patent_app_number] => 273362 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2754424 [patent_doc_number] => 05071972 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1991-12-10 [patent_title] => 'DNA sequences encoding novel thrombolytic proteins' [patent_app_type] => 1 [patent_app_number] => 7/382678 [patent_app_country] => US [patent_app_date] => 1988-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17137 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/071/05071972.pdf [firstpage_image] =>[orig_patent_app_number] => 382678 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2784393 [patent_doc_number] => 05100666 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1992-03-31 [patent_title] => 'Modified tissue plasminogen activator K2K2SP' [patent_app_type] => 1 [patent_app_number] => 7/203370 [patent_app_country] => US [patent_app_date] => 1988-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 9 [patent_no_of_words] => 7169 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 4 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/100/05100666.pdf [firstpage_image] =>[orig_patent_app_number] => 203370 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2891126 [patent_doc_number] => 05244676 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-09-14 [patent_title] => 'Modified tissue plasminogen activator with modified glycosylation site' [patent_app_type] => 1 [patent_app_number] => 7/203047 [patent_app_country] => US [patent_app_date] => 1988-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 14 [patent_no_of_words] => 7715 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 4 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/244/05244676.pdf [firstpage_image] =>[orig_patent_app_number] => 203047 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2966905 [patent_doc_number] => 05258287 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-11-02 [patent_title] => 'DNA encoding and methods of production of insulin-like growth factor binding protein BP53' [patent_app_type] => 1 [patent_app_number] => 7/171623 [patent_app_country] => US [patent_app_date] => 1988-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 19 [patent_no_of_words] => 15976 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/258/05258287.pdf [firstpage_image] =>[orig_patent_app_number] => 171623 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2702598 [patent_doc_number] => 04992274 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1991-02-12 [patent_title] => 'Tissue plasminogen activator A-chain/urokinase B-chain hybrid protein' [patent_app_type] => 1 [patent_app_number] => 7/158542 [patent_app_country] => US [patent_app_date] => 1988-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5525 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/992/04992274.pdf [firstpage_image] =>[orig_patent_app_number] => 158542 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3038198 [patent_doc_number] => 05376547 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-12-27 [patent_title] => 'Des-epidermal growth factor plasminogen activators' [patent_app_type] => 1 [patent_app_number] => 7/150267 [patent_app_country] => US [patent_app_date] => 1988-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 10134 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 147 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/376/05376547.pdf [firstpage_image] =>[orig_patent_app_number] => 150267 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2666829 [patent_doc_number] => 04999194 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1991-03-12 [patent_title] => 'Two-chain urokinase plasminogen activators for treatment of thrombotic disease' [patent_app_type] => 1 [patent_app_number] => 7/143975 [patent_app_country] => US [patent_app_date] => 1988-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4270 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/999/04999194.pdf [firstpage_image] =>[orig_patent_app_number] => 143975 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2665800 [patent_doc_number] => 05047241 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1991-09-10 [patent_title] => 'Tris-Kringle plasminogen activator with novel K2 insert' [patent_app_type] => 1 [patent_app_number] => 7/140068 [patent_app_country] => US [patent_app_date] => 1987-12-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 8 [patent_no_of_words] => 5399 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/047/05047241.pdf [firstpage_image] =>[orig_patent_app_number] => 140068 [rel_patent_id] =>[rel_patent_doc_number] =>)